pET28-His6-Ubc9-C138A
(Plasmid
#133911)
-
PurposeBacterial expression of His6-Ubc9-C138A
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 133911 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET28
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5368
- Total vector size (bp) 5773
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameSUMO-conjugating enzyme UBC9
-
Alt nameUBE2I
-
SpeciesH. sapiens (human)
-
Insert Size (bp)483
-
MutationCysteine 138 to Alanine
-
Entrez GeneUBE2I (a.k.a. C358B7.1, P18, UBC9)
- Promoter T7
-
Tag
/ Fusion Protein
- Thrombin-cleavable His6-tag (N terminal on backbone)
Cloning Information
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer T7
- 3′ sequencing primer T7term (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET28-His6-Ubc9-C138A was a gift from Jeffrey Bode (Addgene plasmid # 133911 ; http://n2t.net/addgene:133911 ; RRID:Addgene_133911) -
For your References section:
Lysine acylation using conjugating enzymes for site-specific modification and ubiquitination of recombinant proteins. Hofmann R, Akimoto G, Wucherpfennig TG, Zeymer C, Bode JW. Nat Chem. 2020 Nov;12(11):1008-1015. doi: 10.1038/s41557-020-0528-y. Epub 2020 Sep 14. 10.1038/s41557-020-0528-y PubMed 32929246